Presenter's Information

Ted Feldman, MD

Country USA
Specialty Interventional Cardiologist
  1. [Invited Case Presentation & Focus Review] TMVR: Prevention of LVOT Obstruction with Alcohol Septal Ablation
  2. Percutaneous Mitral/Tricuspid Repair; State-of-the Art and Future Directions
  3. WATCHMAN Device: Current Application and Future Indications
  4. MitraClip Will Be the Dominant Therapy in Severe FMR - Predicting COAPT
  5. WATCHMAN Device Versus NOAC (New Oral Anticoagulant) Drugs
  6. Mitral Clip 2016: Indication, Clinical Data and Limitations
  7. Current Status of MitraClip
  8. Transcatheter Mitral Valve Therapies: New Advances in Techniques and Devices
  9. Wide Application of Percutaneous LAA Closure: Too Much Early?
  10. The Lotus Valve: Minimization of Paravalvular Leak with a Repositionable Next Generation TAVR Device
  11. LAA Closure: Technical Tips and Lessons from Nightmare Cases
  12. Current Status of Transcatheter Therapies for Mitral Regurgitation
  13. Evolving Transcatheter Mitral Valve Repair and Replacement Therapies
  14. [Are We Ready to Do Transcatheter Treatment for Mitral Regurgitation?] For: Yes! Right Now, Device and Technique Are Already Ready.
  15. Case Presentation: Recurrent Cardioembolic Stroke
  16. Con: No More Device, Lack of Evidence
  17. Percutaneous Mitral Valve Repair(PMVR): From Science to Practice
  18. Counterpoint: PFO Clinical Trial Results (RESPECT and PC) Are Problematic
  19. Trans-catheter Valve Therapies: Aortic and Mitral
  20. Percutaneous Therapy for Mitral Regurgitation
  21. What Are the Longer Term Results of Percutaneous Mitral Valve Repair? What Role Will It Play?
  22. Percutaneous Therapy of Structural Heart Disease Using Imaging Modality
  23. Percutaneous Mitral Repair Update
  24. Establishing an Interventional Program for Congenital and Structural Heart Intervention: Organizational Components, Personnel Requirements, and Institutional Hurdles
  25. How To Disclose and What To Be Disclosed: Conflict of Interest for Physicians and Its Implication in Clinical Trial Conduct
  26. Percutaneous Mitral Valve Repair Therapies
  27. Evalve Randomized Trial Update
  28. i2 Late-Breaking Clinical Trials Highlights
  29. PCI for Left Main & Multivessel CAD: The SYNTAX Trial
  30. The E-valve Edge-to-Edge Repair for Mitral Regurgitation: Design Concept and EVEREST Update
  31. Pre & Post-Dilatation Strategies for DES
Conference Slides
Category